Jeffrey S Farrow is Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 36,704 shares of TARS, which is worth approximately $1.52 Million. The most recent transaction as insider was on Jun 17, 2025, when has been sold 13,608 shares (Common Stock) at a price of $40.42 per share, resulting in proceeds of $550,035. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K
63.63% 3M change
102.38% 12M change
Total Value Held $1.52 Million

Jeffrey S Farrow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2025
SELL
Open market or private sale
$550,035 $40.42 p/Share
13,608 Reduced 27.05%
36,704 Common Stock
Jun 16 2025
BUY
Exercise of conversion of derivative security
-
27,881 Added 35.66%
50,312 Common Stock
Mar 20 2025
SELL
Open market or private sale
$59,430 $50.11 p/Share
1,186 Reduced 5.02%
22,431 Common Stock
Mar 19 2025
SELL
Open market or private sale
$59,439 $47.4 p/Share
1,254 Reduced 5.04%
23,617 Common Stock
Mar 18 2025
SELL
Open market or private sale
$59,436 $46.29 p/Share
1,284 Reduced 4.91%
24,871 Common Stock
Mar 15 2025
BUY
Exercise of conversion of derivative security
-
8,019 Added 23.47%
26,155 Common Stock
Jun 18 2024
SELL
Open market or private sale
$286,924 $27.47 p/Share
10,445 Reduced 36.55%
18,136 Common Stock
Jun 17 2024
BUY
Exercise of conversion of derivative security
-
27,881 Added 49.38%
28,581 Common Stock

Also insider at

GBT
Global Blood Therapeutics, Inc. Healthcare
JSF

Jeffrey S Farrow

Officer
South San Francisco, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS